(Recasts headline and lead)
LONDON, Nov 23 (Reuters) - AstraZeneca said on
Monday its vaccine for the novel coronavirus, developed along
with the University of Oxford, could be around 90% effective
under one dosing regimen.
"This vaccine's efficacy and safety confirm that it will be
highly effective against COVID-19 and will have an immediate
impact on this public health emergency," Pascal Soriot, Astra's
chief executive, said in a statement.
The British drugmaker's preliminary trial results mark a
fresh breakthrough in the fight against a pandemic that has
killed nearly 1.4 million people and roiled the global economy.
(Reporting by Kate Holton in London; Aakash Jagadeesh Babu in
Bengaluru; Editing by Shounak Dasgupta/Guy Faulconbridge)
Astrazeneca (AZN)
